Connor J N, Johnson G F, Solomon H M
Clin Chem. 1976 Jun;22(6):884-8.
We describe a gas-chromatographic method for p-chlorophenoxyisobutyric acid (I) the active metabolite of clofibrate. The drug and internal standards are separated from either serum or saliva by a double extraction procedure and converted to the corresponding butyl esters by reaction with iodobutane in a mixture of methanol and N,N-di-methylacetamide containing tetramethylammonium hydroxide. Within-run CV of this assay at a serum I concentration of 79.2 mg/liter was 2.3% and at a salivary I concentration of 2.5 mg/liter was 2.1%. Precision during four months of the serum and salivary assays at these concentrations was 4.1% and 6.2%, respectively. The mean serum concentration of I (12 h after dose) in patients receiving the drug at an average dose of 28.0 mg/kg per day was 109.6 mg/liter. Serum and salivary concentrations of I as determined by our procedure were used to calculate the unbound fraction of drug in human serum. Such measurements can be used to monitor therapy in patients with renal disease, where drug toxicity may arise from high concentrations of unbound I.
我们描述了一种用于测定氯贝丁酯的活性代谢物对氯苯氧异丁酸(I)的气相色谱法。通过双重萃取程序将药物和内标物从血清或唾液中分离出来,并在含有氢氧化四甲铵的甲醇和N,N - 二甲基乙酰胺的混合物中与碘丁烷反应,转化为相应的丁酯。该测定法在血清I浓度为79.2mg /升时的批内变异系数为2.3%,在唾液I浓度为2.5mg /升时为2.1%。在这些浓度下进行的血清和唾液测定的四个月内精密度分别为4.1%和6.2%。平均日剂量为28.0mg / kg的患者服用该药物后(给药后12小时)血清I的平均浓度为109.6mg /升。通过我们的方法测定的血清和唾液中I的浓度用于计算人血清中药物的游离分数。此类测量可用于监测肾病患者的治疗情况,在这些患者中,药物毒性可能源于高浓度的游离I。